CEO

Summary Box: Bristol says strategy shift paid off

AP News
|
Posted: Jan 10, 2012 5:19 PM
Summary Box: Bristol says strategy shift paid off

OVERHAUL SUCCESS: Bristol-Myers Squibb Co. says its makeover into a pure biopharmaceutical company has resulted in five new product launches, with more expected soon.

ALTERNATE DIVERSIFICATION: Unlike rivals adding vaccine or consumer and animal health businesses, Bristol has chosen to diversify only in the diseases it targets and the technologies used to treat them, from pills to biologic drugs.

HEPATITIS GOAL: With four hepatitis C drugs in testing and plans to buy a hepatitis C drug developer, Bristol is aiming to transform the standard of care for the tough-to-treat virus.